stockrowAtriCure, Inc. (ATRC) vs Azenta, Inc. (AZTA)
- AtriCure, Inc. ATRC 60.70 −7.37%
- Azenta, Inc. AZTA 37.47 −4.27%
AtriCure, Inc. and Azenta, Inc. are both Medical Instruments & Supplies companies. AtriCure, Inc. is the larger, with a market value of $3.1B against $1.6B — 1.9× the size. Azenta, Inc. has negative trailing earnings, so its P/E is not meaningful; AtriCure, Inc. trades at 199×. AtriCure, Inc. grew revenue faster over the last twelve months: 13.8% against 4.80%. AtriCure, Inc. has the higher net margin (2.52% vs −20.0%) and the higher return on invested capital (2.61% vs −9.27%). Across the 20 metrics below, AtriCure, Inc. leads on 14 and Azenta, Inc. on 6.
Valuation
Profitability
| Metric | ATRC | AZTA | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.74% | 44.05% | 53.60% |
| Operating margin | 2.89% | (28.56%) | 1.97% |
| Net margin | 2.52% | (20.02%) | 0.00% |
| Free cash flow margin | 8.98% | 1.61% | 2.36% |
| Return on equity | 2.95% | (7.72%) | 0.00% |
| Return on assets | 2.20% | (6.31%) | 0.00% |
| Return on invested capital | 2.61% | (9.27%) | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack